33 results
An AAV5 vector with a functional factor VIII gene tested in men with hemophilia A #EBM
hemophilia A #EBM ... #Honc #hemophilia ... VisualAbstract #NEJM
Paths to Defective Homologous Recombination DNA Repair in Breast Cancer. Each individual mutation or epigenetic aberration
DNA Repair in Breast ... common feature of breast ... cancer #Pathophys #Honc ... BreastCancer #DNARepair #NEJM
Plasmacytomas and Plasma-Cell Leukemia - Physical examination revealed multiple exophytic subcutaneous lesions involving the arms and
stain) #Clinical #HONC ... #Derm #Plasmacytomas ... Leukemia #Smear #NEJM
Ecthyma Gangrenosum - A physical examination revealed a 2-cm hemorrhagic patch with an erythematous border (Panel
#Clinical #Derm ... #Honc #Ecthyma # ... #Neutropenic #NEJM
Crusted Scabies - Physical examination now revealed a generalized erythematous and scaly rash with intense hyperkeratotic
, interdigital areas ... , and genital areas ... C) #Clinical #Derm ... Scabies #Microscopy #NEJM
Panel A shows a patient with erythematotelangiectatic rosacea, in which diffuse erythema and telangiectasia are present
., convex areas ... #Clinical #Derm ... PrimaryCare #Rosacea #NEJM
Radiation-Induced Angiosarcoma after Breast-Cancer Treatment - Physical examination revealed an area of skin 10 cm in
Angiosarcoma after Breast-Cancer ... the dermis and breast ... #Clinical #Derm ... #Honc #Path #RadiationInducedAngiosarcoma ... Radiation #Microscopy #NEJM
Lymphangitis on the Abdomen - Examination revealed a warm, indurated plaque with extension toward her left
toward her left breast ... #Clinical #Derm ... Lymphangitis #Abdominal #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
the Intention-to-Treat ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
the Intention-to-Treat ... Population #EBM ... #Honc #Nivolumab ... Ipilimumab #Melanoma #NEJM